Half-year report · HY
3583.TEDINET S100WZXL
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥6.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥352m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥489m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥351m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥814m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥454m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥353m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥452m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥10.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥9.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥277m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥637m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥313m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥47m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥160m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥248m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥562m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥391m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥129.18 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.05 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.1 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 69.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥829m |
| Medical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥827m |
| Medical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Medical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥58m |
| Technological Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥448m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Medical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Medical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥65m |
| Technological Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥598m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 531
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ioa | Prior1YearInstant | 62556000 | JPY |
| Other ioa | InterimInstant | 71588000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -5993000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | -5993000 | JPY |
| Investments and other assets | Prior1YearInstant | 279598000 | JPY |
| Investments and other assets | InterimInstant | 395462000 | JPY |
| Noncurrent assets | Prior1YearInstant | 3257172000 | JPY |
| Noncurrent assets | InterimInstant | 3373473000 | JPY |
| Assets | Prior1YearInstant | 9842848000 | JPY |
| Assets | InterimInstant | 9961257000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 163081000 | JPY |
| Notes and accounts payable trade | InterimInstant | 168773000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 327261000 | JPY |
| Electronically recorded obligations operating cl | InterimInstant | 381272000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 552060000 | JPY |
| Current portion of long term loans payable | InterimInstant | 512060000 | JPY |
| Lease obligations cl | Prior1YearInstant | 13088000 | JPY |
| Lease obligations cl | InterimInstant | 14820000 | JPY |
| Income taxes payable | Prior1YearInstant | 144385000 | JPY |
| Income taxes payable | InterimInstant | 103268000 | JPY |
| Provision for bonuses | Prior1YearInstant | 138296000 | JPY |
| Provision for bonuses | InterimInstant | 117337000 | JPY |
| Other cl | Prior1YearInstant | 301091000 | JPY |
| Other cl | InterimInstant | 287593000 | JPY |
| Current liabilities | Prior1YearInstant | 1639264000 | JPY |
| Current liabilities | InterimInstant | 1585127000 | JPY |
| Long term loans payable | Prior1YearInstant | 894330000 | JPY |
| Long term loans payable | InterimInstant | 843140000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 30543000 | JPY |
| Lease obligations ncl | InterimInstant | 31781000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 23719000 | JPY |
| Deferred tax liabilities for land revaluation | InterimInstant | 23719000 | JPY |
| Provision for share based remuneration ncl | Prior1YearInstant | 118936000 | JPY |
| Provision for share based remuneration ncl | InterimInstant | 113313000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 427738000 | JPY |
| Net defined benefit liability | InterimInstant | 411498000 | JPY |
| Other ncl | Prior1YearInstant | 515000 | JPY |
| Other ncl | InterimInstant | 515000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1495783000 | JPY |
| Noncurrent liabilities | InterimInstant | 1423969000 | JPY |
| Liabilities | Prior1YearInstant | 3135047000 | JPY |
| Liabilities | InterimInstant | 3009096000 | JPY |
| Capital stock | Prior1YearInstant | 1939834000 | JPY |
| Capital stock | InterimInstant | 1939834000 | JPY |
| Capital surplus | Prior1YearInstant | 517064000 | JPY |
| Capital surplus | InterimInstant | 517091000 | JPY |
| Retained earnings | Prior1YearInstant | 4328704000 | JPY |
| Retained earnings | InterimInstant | 4582626000 | JPY |
| Treasury stock | Prior1YearInstant | -256105000 | JPY |
| Treasury stock | InterimInstant | -284820000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |